James W. Luckey
Research Triangle Park
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James W. Luckey.
Journal of Substance Abuse Treatment | 1996
Jeffrey A. Hoffman; Barry D. Caudill; Joseph J. Koman; James W. Luckey; Patrick M. Flynn; Dale W. Mayo
The 12-month posttreatment outcome results for a randomized clinical trial that tested the effectiveness of various combinations of 4-month psychosocial treatment interventions are reported for 184 clients who used cocaine. Clients primarily used crack (93%), and the majority were African American (95%). Overall, clients exhibited substantial pre-post treatment gains: reduced regular cocaine use, reduced other drug use, reduced regular alcohol use, and reduced involvement in illegal activities. Logistic regression models produced significant odds ratios showing that those who used cocaine regularly during the year after treatment were more likely to have attended fewer treatment sessions, to be female, to be less educated, to have been regular cocaine users prior to treatment, and to have spent fewer days incarcerated during the 12-months after treatment. It was concluded that treatment positively impacted posttreatment gains, and it was suggested that selective tailoring of additional treatment services may produce additional treatment gains.
Journal of Substance Abuse Treatment | 1995
Patrick M. Flynn; Robert L. Hubbard; James W. Luckey; Barbara H. Forsyth; Timothy K. Smith; Charles D. Phillips; Douglas L. Fountain; Jeffrey A. Hoffman; Joseph J. Koman
The Individual Assessment Profile (IAP), a structured intake assessment interview instrument in the public domain, was designed for use with substance-abusing populations in several large-scale and community-based drug abuse treatment projects underway in the United States. Background information is presented, including the content-based item-selection process used during the pretests and pilot testing. Validity and test-retest reliability data are also presented, along with descriptions of studies using the IAP for clinical, research, and management information purposes. Concordance between biological measures and self-reports of recent drug use, measures of internal consistency, and test-retest reliability coefficients were generally good. A computer-assisted personal interview version of the IAP and an automated reporting system were subsequently developed for clinical and management reporting purposes and used in a large-scale research demonstration project. An intreatment version of the IAP has also been developed to collect information on treatment services provided and to assess changes in behaviors after 3, 6, and 12 months of treatment. These instruments (the IAP intake and intreatment interviews) provide a comprehensive system to assess substance-abusing populations.
American Journal of Drug and Alcohol Abuse | 1994
Barry D. Caudill; Jeffrey A. Hoffman; Robert L. Hubbard; Patrick M. Flynn; James W. Luckey
The purpose of this investigation was to determine if parental substance abuse places children at a higher risk regarding their own substance abuse, illegal activities, and psychological functioning. An intake assessment was conducted with 299 crack smokers currently undergoing treatment. It revealed that clients with a parental history of substance abuse were at over twice the risk for antisocial personality disorders, had been arrested significantly more times as an adult, were more likely to report illicit drug use in the past year, and had received prior treatment more often than clients without a parental history of substance abuse. Surprisingly, no relationship was observed between parental history of substance abuse and preadult behaviors including age-of-onset of drug use, childhood conduct disorders, age at first antisocial behavior, or number of arrests before age 18. Future prevention and treatment efforts with similar populations should recognize the strong influence of the family in the development of substance abuse.
American Journal of Drug and Alcohol Abuse | 1995
Patrick M. Flynn; James W. Luckey; Barry S. Brown; Jeffrey A. Hoffman; George H. Dunteman; Anne C. Theisen; Robert L. Hubbard; Richard Needle; Sid J. Schneider; Joseph J. Koman; Mohammad Atef-Vahid; Samuel Karson; Gary L. Palsgrove; Brian T. Yates
This study was conducted to investigate the relationship between the indicators of psychiatric disorders of individuals and their choice of either cocaine or heroin, drugs that differ markedly in their pharmacological effects. Cocaine acts as an intense stimulant, and heroin has profound sedative effects. This investigation examined the relationship between preference for heroin or cocaine and indicators of psychiatric impairment. Data from 282 subjects were grouped according to drug of choice and analyzed. Ninety-three percent of these subjects were African-American, 32% were female, and the average age was 34. Univariate and multivariate statistical analyses, such as discriminant analyses, were used to determine group differences. The results are evaluated and interpreted in relation to both the current empirical findings and to the hypotheses and theories postulated as a result of earlier clinical observations on drug of choice and psychopathology. Discriminant analysis yielded an overall correct classification rate of 75%. The discriminant function suggests that members in the cocaine drug of choice group as contrasted with members in the heroin preference group can be characterized as more socially inhibited and more self-defeating after adjusting for differences in age, duration of use of illicit substances, and marital status. Those who favored cocaine as contrasted with those who favored heroin were more likely to have never married, be younger, and have used illicit substances for a shorter period of time.
Substance Use & Misuse | 1997
Patrick M. Flynn; Joseph T. McCann; James W. Luckey; Jennifer L. Rounds-Bryant; Anne C. Theisen; Jeffrey A. Hoffman; Joseph J. Koman
The Million Clinical Multiaxial Inventory (MCMI versions I, II, and III) includes a scale to assess drug use problems, Scale T-Drug Dependence. Detailed drug use data from a sample of 659 known drug users along with MCMI-II results were examined to determine the operating characteristics of the MCMI-II drug dependence scale. Operating characteristics, sensitivity, specificity, positive predictive power, negative predictive power, and overall diagnostic power were calculated for base rate cutoffs and for the number of prototypic items endorsed to determine the diagnostic efficiency of Scale T-Drug Dependence in identifying regular drug users. Prototypic item cutoffs provided higher levels of diagnostic and positive predictive power than did the standard base rate cutoffs.
Journal of Addictive Diseases | 1995
Jeffrey A. Hoffman; Barry D. Caudill; Joseph J. Koman; James W. Luckey; Patrick M. Flynn; Robert L. Hubbard
Journal of Personality Disorders | 1996
Patrick M. Flynn; S. Gail Craddock; James W. Luckey; Robert L. Hubbard; George H. Dunteman
Journal of Maintenance in the Addictions | 1997
Dorynne Czechowicz; Robert L. Hubbard; Mph Charles D. Phillips PhD; Douglas L. Fountain Mpa; James R. Cooper; Stephen P. Molinari; James W. Luckey; Laura A. Graham Mpa
RET: revista de toxicomanías | 1998
Patrick M. Flynn; S. Gail Craddock; James W. Luckey; Robert L. Hubbard; George H. Dunteman
Archive | 1999
Patrick M. Flynn; James W. Luckey; Sara C. Wheeless